MONROE COUNTY, Pa. - Sanofi, maker of anti-inflammation drug Dupixent, will report third-quarter earnings Friday before the opening of U.S. markets. Paris-based Sanofi is the parent company of ...

See the latest Sanofi SA ADR stock price (SNY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

BOSTON, MA – Stanford professor, physician, and bestselling author Abraham Verghese began his address to the Class of 2025 by reflecting on his roots — as an immigrant who grew up in Ethiopia ...

France’s Sanofi – a major player in the rare disease category – is offering $30 per share for La Jolla, California-based Inhibrx, which had a closing price of just over $33 yesterday.

France's Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US, saying it intends to spend "at least $20 billion" there by the ...

Alexander Saeedy covers banking and finance for The Wall Street Journal. Previously, he covered financially distressed companies and bankruptcy. His stories have led him to investigate far-flung ...

Sanofi SA ADR SNY Stock XNAS Rating as of Jul 4, 2025 Read Company Report Download PDF ...